Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2018-2033)
2.2 Nanomedicine Growth Trends by Region
2.2.1 Global Nanomedicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Nanomedicine Historic Market Size by Region (2018-2023)
2.2.3 Nanomedicine Forecasted Market Size by Region (2024-2033)
2.3 Nanomedicine Market Dynamics
2.3.1 Nanomedicine Industry Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Revenue
3.1.1 Global Top Nanomedicine Players by Revenue (2018-2023)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2018-2023)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine Revenue
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2022
3.5 Nanomedicine Key Players Head office and Area Served
3.6 Key Players Nanomedicine Product Solution and Service
3.7 Date of Enter into Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2018-2023)
4.2 Global Nanomedicine Forecasted Market Size by Type (2024-2033)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2018-2023)
5.2 Global Nanomedicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nanomedicine Market Size (2018-2033)
6.2 North America Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Nanomedicine Market Size by Country (2018-2023)
6.4 North America Nanomedicine Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2018-2033)
7.2 Europe Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Nanomedicine Market Size by Country (2018-2023)
7.4 Europe Nanomedicine Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size (2018-2033)
8.2 Asia-Pacific Nanomedicine Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Nanomedicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Nanomedicine Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanomedicine Market Size (2018-2033)
9.2 Latin America Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Nanomedicine Market Size by Country (2018-2023)
9.4 Latin America Nanomedicine Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size (2018-2033)
10.2 Middle East & Africa Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Nanomedicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Nanomedicine Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Detail
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2018-2023)
11.1.5 Combimatrix Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Detail
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2018-2023)
11.2.5 Ablynx Recent Development
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Detail
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2018-2023)
11.3.5 Abraxis Bioscience Recent Development
11.4 Celgene
11.4.1 Celgene Company Detail
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2018-2023)
11.4.5 Celgene Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Detail
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2018-2023)
11.5.5 Mallinckrodt Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Detail
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2018-2023)
11.6.5 Arrowhead Research Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Nanosphere
11.10.1 Nanosphere Company Detail
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2018-2023)
11.10.5 Nanosphere Recent Development
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Detail
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2018-2023)
11.11.5 Epeius Biotechnologies Recent Development
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Detail
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2018-2023)
11.12.5 Cytimmune Sciences Recent Development
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Detail
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2018-2023)
11.13.5 Nanospectra Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Quantum dots
Table 3. Key Players of Nanoparticles
Table 4. Key Players of Nanoshells
Table 5. Key Players of Nanotubes
Table 6. Key Players of Nanodevices
Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Nanomedicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Nanomedicine Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Nanomedicine Market Share by Region (2018-2023)
Table 11. Global Nanomedicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Nanomedicine Market Share by Region (2024-2033)
Table 13. Nanomedicine Market Trends
Table 14. Nanomedicine Market Drivers
Table 15. Nanomedicine Market Challenges
Table 16. Nanomedicine Market Restraints
Table 17. Global Nanomedicine Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Nanomedicine Market Share by Players (2018-2023)
Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)
Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicine Product Solution and Service
Table 24. Date of Enter into Nanomedicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicine Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Nanomedicine Revenue Market Share by Type (2018-2023)
Table 28. Global Nanomedicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Nanomedicine Revenue Market Share by Type (2024-2033)
Table 30. Global Nanomedicine Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Nanomedicine Revenue Market Share by Application (2018-2023)
Table 32. Global Nanomedicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Nanomedicine Revenue Market Share by Application (2024-2033)
Table 34. North America Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Nanomedicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Nanomedicine Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Nanomedicine Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Nanomedicine Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Nanomedicine Market Size by Country (2024-2033) & (US$ Million)
Table 49. Combimatrix Company Detail
Table 50. Combimatrix Business Overview
Table 51. Combimatrix Nanomedicine Product
Table 52. Combimatrix Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 53. Combimatrix Recent Development
Table 54. Ablynx Company Detail
Table 55. Ablynx Business Overview
Table 56. Ablynx Nanomedicine Product
Table 57. Ablynx Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 58. Ablynx Recent Development
Table 59. Abraxis Bioscience Company Detail
Table 60. Abraxis Bioscience Business Overview
Table 61. Abraxis Bioscience Nanomedicine Product
Table 62. Abraxis Bioscience Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 63. Abraxis Bioscience Recent Development
Table 64. Celgene Company Detail
Table 65. Celgene Business Overview
Table 66. Celgene Nanomedicine Product
Table 67. Celgene Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 68. Celgene Recent Development
Table 69. Mallinckrodt Company Detail
Table 70. Mallinckrodt Business Overview
Table 71. Mallinckrodt Nanomedicine Product
Table 72. Mallinckrodt Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 73. Mallinckrodt Recent Development
Table 74. Arrowhead Research Company Detail
Table 75. Arrowhead Research Business Overview
Table 76. Arrowhead Research Nanomedicine Product
Table 77. Arrowhead Research Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 78. Arrowhead Research Recent Development
Table 79. GE Healthcare Company Detail
Table 80. GE Healthcare Business Overview
Table 81. GE Healthcare Nanomedicine Product
Table 82. GE Healthcare Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 83. GE Healthcare Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Nanomedicine Product
Table 87. Merck Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Pfizer Company Detail
Table 90. Pfizer Business Overview
Table 91. Pfizer Nanomedicine Product
Table 92. Pfizer Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. Nanosphere Company Detail
Table 95. Nanosphere Business Overview
Table 96. Nanosphere Nanomedicine Product
Table 97. Nanosphere Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 98. Nanosphere Recent Development
Table 99. Epeius Biotechnologies Company Detail
Table 100. Epeius Biotechnologies Business Overview
Table 101. Epeius Biotechnologies Nanomedicine Product
Table 102. Epeius Biotechnologies Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 103. Epeius Biotechnologies Recent Development
Table 104. Cytimmune Sciences Company Detail
Table 105. Cytimmune Sciences Business Overview
Table 106. Cytimmune Sciences Nanomedicine Product
Table 107. Cytimmune Sciences Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 108. Cytimmune Sciences Recent Development
Table 109. Nanospectra Biosciences Company Detail
Table 110. Nanospectra Biosciences Business Overview
Table 111. Nanospectra Biosciences Nanomedicine Product
Table 112. Nanospectra Biosciences Revenue in Nanomedicine Business (2018-2023) & (US$ Million)
Table 113. Nanospectra Biosciences Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicine Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Nanomedicine Market Share by Type: 2022 VS 2033
Figure 3. Quantum dots Features
Figure 4. Nanoparticles Features
Figure 5. Nanoshells Features
Figure 6. Nanotubes Features
Figure 7. Nanodevices Features
Figure 8. Global Nanomedicine Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Nanomedicine Market Share by Application: 2022 VS 2033
Figure 10. oncology Case Studies
Figure 11. Infectious diseases Case Studies
Figure 12. Cardiology Case Studies
Figure 13. Orthopedics Case Studies
Figure 14. Others Case Studies
Figure 15. Nanomedicine Report Years Considered
Figure 16. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Nanomedicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Nanomedicine Market Share by Region: 2022 VS 2033
Figure 19. Global Nanomedicine Market Share by Players in 2022
Figure 20. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2022
Figure 22. North America Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Nanomedicine Market Share by Country (2018-2033)
Figure 24. United States Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Nanomedicine Market Share by Country (2018-2033)
Figure 28. Germany Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Nanomedicine Market Share by Region (2018-2033)
Figure 36. China Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Nanomedicine Market Share by Country (2018-2033)
Figure 44. Mexico Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Nanomedicine Market Share by Country (2018-2033)
Figure 48. Turkey Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Nanomedicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Combimatrix Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 51. Ablynx Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 52. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 53. Celgene Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 54. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 55. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 56. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 59. Nanosphere Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 60. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 61. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 62. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed